Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study
Year: 2025
Type: article
Language: en
Topic: Ocular Oncology and Treatments
Authors and affiliations:
raw_author_name: Mike Wu
raw_affiliation_strings: Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Daniël P. de Bruyn
raw_affiliation_strings: Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Ruben G. Boers
raw_affiliation_strings: Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Aaron B. Beasley
raw_affiliation_strings: Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, 6027, Australia
raw_author_name: Daan M. Hazelaar
raw_affiliation_strings: Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Stavros Makrodimitris
raw_affiliation_strings: Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Joachim B. Boers
raw_affiliation_strings: Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Jolanda Vaarwater
raw_affiliation_strings: Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Ronald O.B. de Keizer
raw_affiliation_strings: The Rotterdam Eye Hospital, Rotterdam, 3011 BH, The Netherlands
raw_author_name: Robert M. Verdijk
raw_affiliation_strings: Department of Pathology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands
Department of Pathology, Section Ophthalmic Pathology, Erasmus University Medical Center, Rotterdam, Rotterdam, 3015 GD, The Netherlands
The Rotterdam Eye Hospital, Rotterdam, 3011 BH, The Netherlands
raw_author_name: Nicole C. Naus
raw_affiliation_strings: Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Dion Paridaens
raw_affiliation_strings: Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
The Rotterdam Eye Hospital, Rotterdam, 3011 BH, The Netherlands
raw_author_name: Saskia M. Wilting
raw_affiliation_strings: Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Elin S. Gray
raw_affiliation_strings: Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, 6027, Australia
raw_author_name: Wilfred F.J. van IJcken
raw_affiliation_strings: Center for Biomics, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Joost Gribnau
raw_affiliation_strings: Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Annelies de Klein
raw_affiliation_strings: Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Erwin Brosens
raw_affiliation_strings: Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands. e.brosens@erasmusmc.nl
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands. e.brosens@erasmusmc.nl
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: Emine Kiliç
raw_affiliation_strings: Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands. e.kilic@erasmusmc.nl
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands. e.kilic@erasmusmc.nl
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, 3015 GD, The Netherlands
raw_author_name: the Rotterdam Ocular Melanoma Studygroup